NCT02850016View on ClinicalTrials.gov

Romidepsin Plus 3BNC117 Phase 2a Study

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Human Immunodeficiency Virus (HIV)
Interventions
DRUG

3BNC117

Intravenous Infusion of 3BNC117

DRUG

Romidepsin

Intravenous Infusion of Romidepsin

Trial Locations (3)

10065

The Rockefeller University, New York

50937

University of Cologne, Cologne

Unknown

Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

University Hospital of Cologne

OTHER

collaborator

Aarhus University Hospital

OTHER

lead

Rockefeller University

OTHER

NCT02850016 - Romidepsin Plus 3BNC117 Phase 2a Study | Biotech Hunter | Biotech Hunter